Chong Kun Dang and MSD Korea’s sales partnership for allergic rhinitis treatment
On the 26th, Chong Kun Dang(CEO Young-Joo Kim) announced a co-marketing agreement of ‘Nasonex,’ a allergic rhinitis treatment, with MSD Korea.
The agreement will allow Chong Kun Dang to exclusively sell and market Nasonex in Korea from January next year.
Nasonex, an original product containin...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
